Physicians' Academy for Cardiovascular Education
Member

HOPE-3 trial suggests that statin therapy is beneficial even in low-risk populations

May 16, 2016 - Dubai, United Arab Emirates - Kausik Ray, MD (Imperial College, London, UK)